Skip to main content
Mona Mashayekhi, MD, Endocrinology, Nashville, TN

Mona Mashayekhi MD PhD

Diabetes, Obesity


Instructor

Join to View Full Profile
  • 1215 21st Ave SFl 8Nashville, TN 37232

  • Phone+1 615-343-8332

  • Fax+1 615-343-8346

Dr. Mashayekhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Mona Mashayekhi is an endocrinologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. She received her medical degree from Washington University School of Medicine in St. Louis and has been in practice 7 years. She specializes in diabetes and endocrinology.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2017 - 2020
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2016 - 2017
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2014 - 2016
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2013
  • University of Chicago
    University of ChicagoBA, Biology, 2000 - 2004

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2015 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

Lectures

  • Diabetes: From Genetics to Novel Therapeutic Targets 
    ENDO 2019 - New Orleans, LA - 3/23/2019

Press Mentions

  • Pairing Drugs like Ozempic with SGLT2 Meds May Help Reduce Heart Attack, Stroke Risks
    Pairing Drugs like Ozempic with SGLT2 Meds May Help Reduce Heart Attack, Stroke RisksJuly 10th, 2024
  • Researchers Find Signs That Gestational Diabetes May Increase Risk of Type 1 Diabetes
    Researchers Find Signs That Gestational Diabetes May Increase Risk of Type 1 DiabetesMay 25th, 2021
  • VUMC in the News: Sept. 19, 2023
    VUMC in the News: Sept. 19, 2023September 15th, 2023
  • Join now to see all

Grant Support

  • The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial FunctionVANDERBILT UNIVERSITY MEDICAL CENTER2023–2028

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: